Back
bluebird bio Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
27
BLUE
bluebird bio
Last Price:
0.46
Seasonality Move:
4.77%
Sell
44
VRTX
Vertex Pharmaceuticals
Last Price:
473.23
Seasonality Move:
6.39%
Sell
27
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy, Sell or Hold?
- The current bluebird bio [BLUE] share price is $0.46. The Score for BLUE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $473.31. The Score for VRTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLUE Stock Price Chart
What is bluebird bio's stock price today?
-
The bluebird bio share price today is $0.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing selling pressure, which indicates risk of future bearish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $473.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
BLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 38.91 | Sell |
| Chaikin Money Flow: | -1691575 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.48 - 0.52) | Sell |
| Bollinger Bands (100): | (0.49 - 1.03) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 49.18 | Sell |
| Chaikin Money Flow: | 377783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (461.94 - 481.58) | Buy |
| Bollinger Bands (100): | (466.4 - 488.64) | Sell |
BLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.48 | Sell |
| 20-day SMA: | 0.49 | Sell |
| 50-day SMA: | 0.53 | Sell |
| 200-day SMA: | 0.95 | Sell |
| 8-day EMA: | 0.48 | Sell |
| 20-day EMA: | 0.49 | Sell |
| 50-day EMA: | 0.57 | Sell |
| 200-day EMA: | 1.17 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 474 | Sell |
| 20-day SMA: | 474.41 | Sell |
| 50-day SMA: | 473.74 | Sell |
| 200-day SMA: | 450.59 | Buy |
| 8-day EMA: | 473.97 | Sell |
| 20-day EMA: | 473.73 | Sell |
| 50-day EMA: | 473.49 | Sell |
| 200-day EMA: | 448.7 | Buy |
bluebird bio Earnings Growth & BLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.46 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.89 per share, and an increase next year of $18.49 per share.
bluebird bio Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||